BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Tufman A, Kahnert K, Duell T, Kauffmann-Guerrero D, Milger K, Schneider C, Stump J, Syunyaeva Z, Huber RM, Reu S. Frequency and clinical relevance of EGFR mutations and EML4-ALK translocations in octogenarians with non-small cell lung cancer. Onco Targets Ther 2017;10:5179-86. [PMID: 29123416 DOI: 10.2147/OTT.S140472] [Cited by in Crossref: 3] [Cited by in F6Publishing: 7] [Article Influence: 0.5] [Reference Citation Analysis]
Number Citing Articles
1 Zhong WX, Wei XF. Coexistence of anaplastic lymphoma kinase rearrangement in lung adenocarcinoma harbouring epidermal growth factor receptor mutation: A single-center study. World J Clin Cases 2022; 10(33): 12164-12174 [DOI: 10.12998/wjcc.v10.i33.12164] [Reference Citation Analysis]
2 Hattori S, Ojima E, Okauchi S, Sasatani Y, Shiozawa T, Satoh H, Hizawa N. Octogenarians With Anaplastic Lymphoma Kinase-rearranged Non-small-cell Lung Cancer: A Case Series. Cancer Diagn Progn 2022;2:711-5. [PMID: 36340445 DOI: 10.21873/cdp.10165] [Reference Citation Analysis]
3 Reiman LT, Walker ZJ, Babcock LR, Forsberg PA, Mark TM, Sherbenou DW. A case for improving frail patient outcomes in multiple myeloma with phenotype‐driven personalized medicine. Aging and Cancer 2021;2:6-12. [DOI: 10.1002/aac2.12022] [Reference Citation Analysis]
4 Li P, Gao Q, Jiang X, Zhan Z, Yan Q, Li Z, Huang C. Comparison of Clinicopathological Features and Prognosis between ALK Rearrangements and EGFR Mutations in Surgically Resected Early-stage Lung Adenocarcinoma. J Cancer 2019;10:61-71. [PMID: 30662526 DOI: 10.7150/jca.26947] [Cited by in Crossref: 16] [Cited by in F6Publishing: 21] [Article Influence: 4.0] [Reference Citation Analysis]
5 Ginsburg GS, Haga SB. Foundations and Application of Precision Medicine. Emery and Rimoin's Principles and Practice of Medical Genetics and Genomics 2019. [DOI: 10.1016/b978-0-12-812537-3.00002-0] [Reference Citation Analysis]
6 Yu Y, Liu D, Liu Z, Li S, Ge Y, Sun W, Liu B. The inhibitory effects of COL1A2 on colorectal cancer cell proliferation, migration, and invasion. J Cancer 2018;9:2953-62. [PMID: 30123364 DOI: 10.7150/jca.25542] [Cited by in Crossref: 34] [Cited by in F6Publishing: 36] [Article Influence: 6.8] [Reference Citation Analysis]